Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock The VITAMINS Randomized Clinical Trial
Author
Fujii, T; Luethi, N; Young, PJ; Frei, DR; Eastwood, GM; French, CJ; Deane, AM; Shehabi, Y; Hajjar, LA; Oliveira, G; ...Date
2020-02-04Source Title
JAMA: Journal of the American Medical AssociationPublisher
AMER MEDICAL ASSOCUniversity of Melbourne Author/s
Bellomo, Rinaldo; Deane, Adam; French, Craig; McGain, Forbes; Bailey, Michael; Udy, Andrew; Naorungroj, Thummaporn; Byrne, Kathleen; Hudson, Elizabeth; YOUNG, MEREDITH; ...Affiliation
Medicine and RadiologyMedicine and Radiology
Medicine and Radiology
Melbourne University Sport
Nursing
University General
Florey Department of Neuroscience and Mental Health
Metadata
Show full item recordDocument Type
Journal ArticleCitations
Fujii, T., Luethi, N., Young, P. J., Frei, D. R., Eastwood, G. M., French, C. J., Deane, A. M., Shehabi, Y., Hajjar, L. A., Oliveira, G., Udy, A. A., Orford, N., Edney, S. J., Hunt, A. L., Judd, H. L., Bitker, L., Cioccari, L., Naorungroj, T., Yanase, F. ,... Trapani, T. (2020). Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock The VITAMINS Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 323 (5), pp.423-431. https://doi.org/10.1001/jama.2019.22176.Access Status
Access this item via the Open Access locationOpen Access URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029761/Abstract
Importance: It is unclear whether vitamin C, hydrocortisone, and thiamine are more effective than hydrocortisone alone in expediting resolution of septic shock. Objective: To determine whether the combination of vitamin C, hydrocortisone, and thiamine, compared with hydrocortisone alone, improves the duration of time alive and free of vasopressor administration in patients with septic shock. Design, Setting, and Participants: Multicenter, open-label, randomized clinical trial conducted in 10 intensive care units in Australia, New Zealand, and Brazil that recruited 216 patients fulfilling the Sepsis-3 definition of septic shock. The first patient was enrolled on May 8, 2018, and the last on July 9, 2019. The final date of follow-up was October 6, 2019. Interventions: Patients were randomized to the intervention group (n = 109), consisting of intravenous vitamin C (1.5 g every 6 hours), hydrocortisone (50 mg every 6 hours), and thiamine (200 mg every 12 hours), or to the control group (n = 107), consisting of intravenous hydrocortisone (50 mg every 6 hours) alone until shock resolution or up to 10 days. Main Outcomes and Measures: The primary trial outcome was duration of time alive and free of vasopressor administration up to day 7. Ten secondary outcomes were prespecified, including 90-day mortality. Results: Among 216 patients who were randomized, 211 provided consent and completed the primary outcome measurement (mean age, 61.7 years [SD, 15.0]; 133 men [63%]). Time alive and vasopressor free up to day 7 was 122.1 hours (interquartile range [IQR], 76.3-145.4 hours) in the intervention group and 124.6 hours (IQR, 82.1-147.0 hours) in the control group; the median of all paired differences was -0.6 hours (95% CI, -8.3 to 7.2 hours; P = .83). Of 10 prespecified secondary outcomes, 9 showed no statistically significant difference. Ninety-day mortality was 30/105 (28.6%) in the intervention group and 25/102 (24.5%) in the control group (hazard ratio, 1.18; 95% CI, 0.69-2.00). No serious adverse events were reported. Conclusions and Relevance: In patients with septic shock, treatment with intravenous vitamin C, hydrocortisone, and thiamine, compared with intravenous hydrocortisone alone, did not significantly improve the duration of time alive and free of vasopressor administration over 7 days. The finding suggests that treatment with intravenous vitamin C, hydrocortisone, and thiamine does not lead to a more rapid resolution of septic shock compared with intravenous hydrocortisone alone. Trial Registration: ClinicalTrials.gov Identifier: NCT03333278.
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References
Collections
- Minerva Elements Records [53102]
- Florey Department of Neuroscience and Mental Health - Research Publications [1300]
- University General - Research Publications [467]
- Nursing - Research Publications [206]
- Melbourne University Sport - Research Publications [5]
- Medicine and Radiology - Research Publications [3320]
- Medicine and Radiology - Research Publications [3320]
- Medicine and Radiology - Research Publications [3320]